SNN - Smith & Nephew SNATS - Stock & Dividends

Smith & Nephew plc is a leading medical technology company that designs, manufactures, and markets a wide range of innovative medical devices and services globally. The company operates through three main business segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management.

In the Orthopaedics segment, Smith & Nephew offers a comprehensive portfolio of products for joint reconstruction, including knee and hip implants, as well as trauma and extremities products for fracture stabilization and deformity correction. These products are designed to help patients regain mobility and improve their quality of life.

The Sports Medicine & ENT segment provides a range of products and technologies for minimally invasive surgery, soft tissue repair, and joint reconstruction. This includes arthroscopic enabling technologies, such as fluid management systems, high-definition cameras, and radio frequency devices, which enable surgeons to perform complex procedures with greater precision and accuracy.

In the Advanced Wound Management segment, Smith & Nephew offers a broad range of products and solutions for the treatment and prevention of acute and chronic wounds. This includes advanced wound bioactives, such as biologics and bioactive technologies, as well as advanced wound devices, including negative pressure wound therapy and hydrosurgery systems. These products are designed to promote wound healing, reduce the risk of complications, and improve patient outcomes.

Smith & Nephew's products and services are used by healthcare providers around the world, and the company is committed to delivering innovative solutions that improve patient care and outcomes. With a rich history dating back to 1856, Smith & Nephew is headquartered in Watford, UK, and has a strong presence in over 100 countries globally.